- Home
- SGMT vs CGNT Comparison
SGMT vs CGNT Comparison
Compare SGMT & CGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | CGNT |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 648.1M | 592.2M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SGMT | CGNT |
|---|---|---|
| Price | $8.00 | $8.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $27.91 | $12.33 |
| AVG Volume (30 Days) | ★ 1.4M | 487.2K |
| Earning Date | 11-12-2026 | 09-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | N/A |
| Revenue This Year | N/A | $11.71 |
| Revenue Next Year | N/A | $10.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $6.29 |
| 52 Week High | $11.45 | $12.31 |
Technical Indicators
Market Signals| Indicator | SGMT | CGNT |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 46.93 |
| Support Level | $6.21 | $7.88 |
| Resistance Level | $11.33 | $8.98 |
| Average True Range (ATR) | 0.56 | 0.29 |
| MACD | -0.14 | -0.01 |
| Stochastic Oscillator | 16.37 | 35.14 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.